Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики МолдоваfiledCriticalНациональный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова
Priority to MDS20140091ApriorityCriticalpatent/MD918Z/en
Publication of MD918YpublicationCriticalpatent/MD918Y/en
Publication of MD918ZpublicationCriticalpatent/MD918Z/en
The invention relates to medicine, in particular to infectious diseases and can be used for the treatment of enteroviral meningitis in children.According to the invention, the claimed method consists in that it is performed the basic therapy, comprising compliance with hygiene regimen, diet, bed rest in the acute period, pathogenetic, symptomatic, detoxification and cerebral circulation improving treatment, at the same time additionally per os is administered 5α-furostan-3β,22,26-triol-3-[O-β-D-glucopyranosyl-(1→2)-β-D- glucopyranosyl(1→4)-β-D-galactopyranosyl]-26-O-β-D-glucopyranoside), 100 mg 2 times a day, 30 minutes before meal, for 30 days.
MDS20140091A2014-06-182014-06-18Method for treating enteroviral meningitis in children
MD918Z
(en)